Your browser doesn't support javascript.
loading
Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy.
Medler, Terry R; Murugan, Dhaarini; Horton, Wesley; Kumar, Sushil; Cotechini, Tiziana; Forsyth, Alexandra M; Leyshock, Patrick; Leitenberger, Justin J; Kulesz-Martin, Molly; Margolin, Adam A; Werb, Zena; Coussens, Lisa M.
Afiliação
  • Medler TR; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Knight Cancer Research Building Room 3030, 2720 SW Moody Avenue, #KC-CDCB, Portland, OR 97201-5042, USA.
  • Murugan D; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Knight Cancer Research Building Room 3030, 2720 SW Moody Avenue, #KC-CDCB, Portland, OR 97201-5042, USA.
  • Horton W; Department of Biomedical Engineering, Program in Computational Biology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Kumar S; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Knight Cancer Research Building Room 3030, 2720 SW Moody Avenue, #KC-CDCB, Portland, OR 97201-5042, USA.
  • Cotechini T; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Knight Cancer Research Building Room 3030, 2720 SW Moody Avenue, #KC-CDCB, Portland, OR 97201-5042, USA.
  • Forsyth AM; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Knight Cancer Research Building Room 3030, 2720 SW Moody Avenue, #KC-CDCB, Portland, OR 97201-5042, USA.
  • Leyshock P; Department of Biomedical Engineering, Program in Computational Biology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Leitenberger JJ; Department of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Kulesz-Martin M; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Knight Cancer Research Building Room 3030, 2720 SW Moody Avenue, #KC-CDCB, Portland, OR 97201-5042, USA; Department of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA; Knight
  • Margolin AA; Department of Biomedical Engineering, Program in Computational Biology, Oregon Health & Science University, Portland, OR 97239, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
  • Werb Z; Department of Anatomy, Helen Diller Family Comprehensive Cancer Center, Parker Immunotherapy Cancer Institute, University of California, San Francisco, CA 94143, USA.
  • Coussens LM; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Knight Cancer Research Building Room 3030, 2720 SW Moody Avenue, #KC-CDCB, Portland, OR 97201-5042, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA. Electroni
Cancer Cell ; 34(4): 561-578.e6, 2018 10 08.
Article em En | MEDLINE | ID: mdl-30300579
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complemento C5a / Receptor da Anafilatoxina C5a / Tratamento Farmacológico / Carcinogênese Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complemento C5a / Receptor da Anafilatoxina C5a / Tratamento Farmacológico / Carcinogênese Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article